{"id":"W2063123552","doi":"10.1002/cncr.22036","title":"Consensus report of the International Society of Gastrointestinal Oncology on therapeutic progress in advanced pancreatic cancer","year":2006,"lang":"en","type":"article","venue":"Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Erlotinib; Cetuximab; Gemcitabine; Bevacizumab; Oncology; Pancreatic cancer; Clinical trial; Oxaliplatin; Capecitabine; Internal medicine; Cancer; Progression-free survival; Targeted therapy; Colorectal cancer; Epidermal growth factor receptor; Overall survival; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03030369,0.00164382,0.003624841,0.004540242,0.001936386,0.003355904,0.004146675,0.00935696,0.003391056],"category_scores_gemma":[0.02655572,0.0007048334,0.002637025,0.006259555,0.001546763,0.002391961,0.003152217,0.01055672,0.003726885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004289446,"about_ca_system_score_gemma":0.01762755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00525561,"about_ca_topic_score_gemma":0.007557177,"domain_scores_codex":[0.9841275,0.004142027,0.005290902,0.000865961,0.004572812,0.001000826],"domain_scores_gemma":[0.9472156,0.009385964,0.005062679,0.001233685,0.03117873,0.005923482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002194834,0.0001144777,0.002270218,0.003291062,0.0001238584,0.0003628955,0.0002928159,0.000517753,0.000757622,0.001521397,0.8224087,0.1681197],"study_design_scores_gemma":[0.00008271306,0.0001458412,0.00486859,0.003512742,0.0002177035,0.0006949165,0.000379714,0.0002808951,0.0006062274,0.00161106,0.9875425,0.00005722361],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.00384929,0.2374224,0.01302445,0.4198737,0.2857493,0.002731466,0.004040305,0.0002855836,0.0330235],"genre_scores_gemma":[0.04380622,0.4680893,0.07116465,0.1537905,0.1869,0.006724049,0.01462296,0.0005839946,0.05431839],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03030369,"threshold_uncertainty_score":0.1602631,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04230732459078521,"score_gpt":0.3999102647213624,"score_spread":0.3576029401305773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}